CS Scar PregnancyNCT07398625
Management of Cesarean Section Scar Ectopic Pregnancy: Sohag University Experience
An observational study of CS Scar Pregnancy, run by Sohag University at 1 site in Egypt.
Trial summary
management of CS scar ectopic pregnancy Read more about this study
- Who is it for?
- Ages 18 to 40 years, women only
- Conditions the study is for
- CS Scar Pregnancy
- What is being tested?
- Observation
- How many people
- 37 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Jan 2024to 1 Dec 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 40 years
- Women only
- No healthy volunteers
- Adult
Study population: 1st trimester pregnancy (6-10) weeks Age: (18-40) years All types of scar ectopic pregnancy endophytic and exophytic types Viable and non-viable scar ectopic.
Who may be able to join
- 1st trimester pregnancy (6-10) weeks Age: (18-40) years All types of scar ectopic pregnancy endophytic and exophytic types Viable and non-viable scar ectopic.
Who cannot join
- Patients with serious systemic diseases will be excluded, such as; heart disease, thrombocytopenia, bronchial asthma and systemic lupus erythematosus because these conditions may affect treatment options and efficacy.
Trial locations and contacts
1 site in 1 country.
About this study
management of CS scar ectopic pregnancy
- Conditions
- CS Scar Pregnancy
- Being tested
- Observation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ObservationOther
observation of cs scar pregnancy cases \&their management in Sohag University
What is being measured
The primary outcome is the main question the study is designed to answer.
irregular uterine bleeding and hematoma formation after surgical evacuation
Measured: 18 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Feb 2026
- Study start1 Jan 2024
- Primary completion1 Dec 2025
- Study completion1 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CS Scar PregnancyStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 37 participants (actual)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Reem Kamel lotfy, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07398625
- Sponsor's protocol ID
- Soh-Med--25-4-11MS
- Status last verified
- Feb 2026
- First submitted
- 11 May 2025
- Last updated
- 10 Feb 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 10 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Management of Cesarean Section Scar Ectopic Pregnancy: Sohag University Experience
- ClinicalTrials.gov ID
- NCT07398625
- Acronym / sponsor ID
- Soh-Med--25-4-11MS
- Conditions
- CS Scar Pregnancy
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 37 participants (actual)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 1 Jan 2024 (actual)
- Primary completion
- 1 Dec 2025 (actual)
- Study completion
- 1 Dec 2025 (actual)
- First posted
- 10 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
management of CS scar ectopic pregnancy
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 to 40 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- 1st trimester pregnancy (6-10) weeks Age: (18-40) years All types of scar ectopic pregnancy endophytic and exophytic types Viable and non-viable scar ectopic.
Key inclusion criteria (1 listed)
- 1st trimester pregnancy (6-10) weeks Age: (18-40) years All types of scar ectopic pregnancy endophytic and exophytic types Viable and non-viable scar ectopic.
Key exclusion criteria (1 listed)
- Patients with serious systemic diseases will be excluded, such as; heart disease, thrombocytopenia, bronchial asthma and systemic lupus erythematosus because these conditions may affect treatment options and efficacy.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Observationobservation of cs scar pregnancy cases \&their management in Sohag University | Other | – |
Primary outcome
irregular uterine bleeding and hematoma formation after surgical evacuation
Time frame: 18 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Feb 2026.
- Individual participant dataSharing planned: Undecided
Related trials for CS Scar Pregnancy
Not yet recruitingObservational study
Effect of Methotrexate on Blood Loss During Laparoscopic Management of CS Scar Pregnancy
Cesarean Scar Pregnancy
Recruiting
Combined Hystroscopic and Laparoscopic Repair of CS Scar Disorder
Cesarean Section Complications, Abnormal Uterine Bleeding
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of CS Scar Pregnancy, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
irregular uterine bleeding and hematoma formation after surgical evacuation (time frame: 18 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Feb 2026.